Default

Technology Boom in Wound Closure Products Offers New Promise For Reducing Trauma While peeding Up Recovery

Pleasanton, CA, pril 18, 2011 – Marketstrat Inc. is pleased to announce the release of our new report titled “Wound Closure Products Markets Worldwide.”

The wound closure device market is characterized by a wide range of competing technologies from traditional sutures to the latest tissue adhesives. While trauma wounds as well as surgical wounds require closure, technological advancement is aimed primarily at addressing surgical wound closure. The products aim to reduce infection rates, provide effective hemostasis, provide a microbial barrier and promote faster healing as well as being easier to administer. A general shift toward minimally invasive procedures presents new challenges for wound closure include vascular sealing and tissue closure.

According to Marketstrat Inc., the wound closure market is growing worldwide at a CAGR of almost 6 percent. This market, currently estimated to be just over $6.3 billon is generating new demand due to growing rates of surgical procedures. High growth product segments are hemostats and tissue adhesives/ sealants. Soaring rates of surgical procedures worldwide, in particular vascular procedures and endoscopic procedures are creating demand for easy to-use, biocompatible, fast-acting and more efficacious closure agents. According to the Marketstrat report entitled, ‘Wound Closure Products
Markets Worldwide’, China’s emerging healthcare infrastructure will soon lead to one of the fastest growing markets for wound closure products.

Innovative products have been developed in every wound closure product category. Some of the recently introduced products include:

Hemostats:

a) OMNEX™ Surgical Sealant (Ethicon) - vascular reconstructions also has adjunctive hemostatic properties. Ethicon reports that clinical trials indicate a hemostatic rate that is three times faster than oxidized regenerated cellulose.

b) PerClot from CryoLife - is a synthetic absorbable modified polymer (AMP®) for use as a hemostat in surgical procedures or following traumatic injuries.

Sutures:

a) The V-loc 90 and 180 knotless wound closure device from Covidien speed up suturing by eliminating the need for knot-tying.

Staples and Clips:

a) Insorb staples (Incisive Surgical Inc.) are fully absorbable within a few months.
b) The EES intraluminal Stapler (Ethicon), uses3-D staple technology, to produce angled, parallel staple legs that overlap
c) NiTi Surgical Solutions - the BioDynamix™ Anastomosis is an alternative to staples.

Surgically resected tissue can be compressed using nitinol based elements.

Adhesives:

a) DuraSeal™ spine sealant and VascuSeal(TM) for vascular reconstructions (Covidien)
b) LiquiBand tissue adhesive (Advanced Medical Solutions) is a fast setting cyanoacyrlate adhesive for surgical wounds
c) TissuePatchDural (TissueMed Ltd.) is an innovative neural adhesive film
d) ProGEL® from Neomend Inc. is a new hydrogel sealant designed to seal air leaks incurred during pulmonary surgery

Tapes/ Strips

a) Prineo Skin Closure System (Ethicon) consists of an applicator containing a self-adhesive mesh and a pen applicator containing 2-octyl cyanoacrylate to polymerize the mesh.

Ethicon and Covidien lead the wound closure market in most product segments. Other major players are Baxter, B Braun, 3M and Smith and Nephew. Niche players with innovative products include CryoLife, GluStitch, Medafor, Thermogenesis and Advanced Medical Solutions.

Companies Discussed

Abbott Vascular Devices, ACE Surgical Supply, Inc., ACUFIRM Ernst Kratz GmbH, Adhezion Biomedical, LC, Advanced Medical Solutions Group plc., AliMed, Inc., AMD-Ritmed Inc., Angiotech Pharmaceuticals, nc., Argentum Medical LLC, Aspen Surgical Products, Aspen Medical Europe Ltd., Baxter International

Inc., B Braun Melsungen AG, C. R. Bard, Inc., Bard Medical Division, Bard/ Davol Inc., Beiersdorf AG, etasan Bant Sanayi Ticaret A.Ş., Brennen Medical, LLC, BSN medical GmbH, Catgut GmbH, CellPoint cientific Inc., Clinisut, CLOSURE Medical Corporation, Cohera Medical Inc., Coloplast, ConvaTec, Covidien, Codman & Shurtleff, Inc., CP Medical, Crest Medical, Cryolife Inc., Cypress Medical Products, Derma Sciences Inc., Dermapac, Inc., DeRoyal Industries Inc., DISPOMEDICA GmbH, D-tek Surgical Suture, Division, Dukal Corp., Dynek Pty Ltd., Ethicon, Inc., Facet Technologies LLC., Ferndale Laboratories Inc., Ferris Mfg Corp., Full Aid Co. Ltd., Gabler Medical Ltd., Genzyme Corp., Gentell Inc., Geritrex Corp., GluStitch Inc., Gramm medical GmbH, Haemacure Corporation, Harvard Apparatus Inc., Homann-Medical GmbH & Co KG, Hu-Friedy, Incisive Surgical, Inc., Integra LifeSciences, Kencap Ltd., Kimberly-Clark Health Care, King Pharmaceuticals Inc., LifeBond, Lifecore Biomedical, LLC, LifeScience Plus, Lohmann & Rauscher Intl. GmbH & Co KG, LSL Industries Inc., Luxilon Industries Co NV, Medafor, Inc., Medela Inc., Medical Technique Inc., Medicon eG, Medi-Globe GmbH, Medi-Tech International
Corp., Medline Industries Inc., Meyer-Haake Medical Innovations, Neomend Inc., NiTi Surgical Solutions, Ltd., Noba Verbandmittel Danz GmbH und Co KG, Nopa Instruments, Orthocon, Orthovita, Orhan Boz Medical Device and Ind. Co., PAUL HARTMANN AG, Pharmaplast, P J Dahlhausen & Co GmbH,
Protein Polymer Technologies Inc., RESORBA Wundversorgung GmbH & Co. KG., Smith & Nephew, Inc., Starch Medical Inc., Southwest Technologies, Inc., SURU International Pvt Ltd., Sutures India Pvt Ltd., Sutures Ltd., Synovis Surgical Innovations, Systagenix Wound Management, TEI Biosciences, Teleflex Medical, Thermogenesis, TissueMed, URGO Medical, Vascular Soutions Inc., WL Gore and Associates, ZymoGenetics

For more details on this report please click here